SomnoMed Limited (SOMNF)
- Previous Close
0.2800 - Open
0.2800 - Bid --
- Ask --
- Day's Range
0.2800 - 0.2800 - 52 Week Range
0.2800 - 0.7900 - Volume
3,000 - Avg. Volume
0 - Market Cap (intraday)
38.102M - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively. In addition, it also provides sleep test at home under the Sunrise brand name. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.
somnomed.com/au/Recent News: SOMNF
Performance Overview: SOMNF
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SOMNF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SOMNF
Valuation Measures
Market Cap
19.23M
Enterprise Value
22.89M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.56
Price/Book (mrq)
1.98
Enterprise Value/Revenue
0.26
Enterprise Value/EBITDA
-30.17
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.94%
Return on Assets (ttm)
-6.34%
Return on Equity (ttm)
-38.28%
Revenue (ttm)
88.77M
Net Income Avi to Common (ttm)
-10.51M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
12.84M
Total Debt/Equity (mrq)
62.00%
Levered Free Cash Flow (ttm)
-6.26M